Details of the Drug-Related molecule(s) Interaction Atlas
General Information of Drug (ID: DMU2ZFK)
| Drug Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Apra (Cell Therapeutics, US, US); 1-[11-(Dodecylamino)-10-hydroxyundecyl]-3,7-dimethylxanthine | |||||||||||||||||||
| Indication | 
 | |||||||||||||||||||
| Cross-matching ID | ||||||||||||||||||||
Molecule-Related Drug Atlas
| Molecule-Related Drug Atlas Molecule Type: DTT Drug Status: Clinical Trial Drug(s) Investigative Drug(s) | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 
								Drug(s) Targeting Cholinephosphate cytidylyltransferase (PCYT1B) 
								 
 | ||||||||||||||||||||||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
| Molecular Interaction Atlas | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|  Drug Therapeutic Target (DTT) | 
 | ||||||||||||||||||||||||||
References
